Search

ISSN: 2228-5881 eISSN: 2251-7308

Submit Your Paper Instructions for Authors Aims and Scope Editorial Board Editorial Policies Publication Ethics Indexing Info About APB & Contacts Indexing and Abstracting Articles In Press Archive

Journal Info:

Freq.: Quarterly

eISSN: 2251-7308
pISSN: 2228-5881

Permission: CC By

Platinum Open Access

(no submission or publication fees)

Powered by

Abstracting and Indexing

PubMed Central, Pubmed,

Emerging Sources Citation Index

Scopus, Google Scholar,

EMBASE/Excerpta Medica

EBSCOhost; CAS: DOAJ

SCImago Journal & Country Rank

2024, Vol 14, No. 4

Advanced Pharmaceutical Bulletin (APB) is a peer-reviewed multidisciplinary open access journal, covering a wide range of various integrative fields with Pharmaceutical sciences.
APB is the official journal of Drug Applied Research Center and Faculty of Pharmacy, published by TUOMS PRESS, Tabriz University of Medical Sciences.

Publication Advantages in Advanced Pharmaceutical Bulletin are:

Free of charge publication for all types of articles
Fast and constructive peer review
Easy and quick online submission of manuscripts
Author friendly review
Rapid publication by means of running issue concept, which gives authors the benefit of 'No Waiting Time' for the officially accepted manuscripts
Free publication of color images
Worldwide visibility of papers (Open Access Journal)

Research Article

1. siRNA-Mediated Silencing of CIP2A Enhances Docetaxel Activity Against PC-3 Prostate Cancer Cells

Saiedeh Razi Soofiyani, Akbar Mohammad Hoseini, Ali Mohammadi, Vahid Khaze Shahgoli, Behzad Baradaran*, Mohammad Saeid Hejazi*

Adv Pharm Bull. 2017;7(4): 637-643. doi: 10.15171/apb.2017.076

PMCID: PMC5788219 PMID: 29399554 Scopus ID: 85043370193

Article

PDF

XML

Cited By:

12

9

10

Research Article

2. Synergetic Impact of Combined 5-Fluorouracil and Rutin on Apoptosis in PC3 Cancer Cells through the Modulation of P53 Gene Expression

Atefeh Satari , Sayed Asadollah Amini , Elham Raeisi , Yves Lemoigne , Esfandiar Heidarian*

Adv Pharm Bull. 2019;9(3): 462-469. doi: 10.15171/apb.2019.055

PMCID: PMC6773939 PMID: 31592435 Scopus ID: 85070477078

Article

PDF

XML

Cited By:

25

13

40

Research Article

3. Downregulation of HMGA2 by Small Interfering RNA Affects the Survival, Migration, and Apoptosis of Prostate Cancer Cell Line

Shima Khajouee , Elham Baghbani, Ali Mohammadi, Behzad Mansoori, Dariush Shanehbandi, Khalil Hajiasgharzadeh, Behzad Baradaran*

Adv Pharm Bull. 2022;12(2): 398-403. doi: 10.34172/apb.2022.039

PMCID: PMC9106948 PMID: 35620335 Scopus ID: 85128137378

Article

PDF

Full Text

XML

Cited By:

0

0

2

Mini Review

4. Multiwalled Carbon Nanotubes as Nanomaterial Tool in the Management of Prostate Cancer: A Possible Nanoformulation Approach

Raja Murugesan , Raman Sureshkumar* , Arun Radhakrishnan, Srikanth Jupudi, Manisha Chennu

Adv Pharm Bull. 2022;12(3): 509-514. doi: 10.34172/apb.2022.053

PMCID: PMC9348525 PMID: 35935048 Scopus ID: 85140415991

Article

PDF

Full Text

XML

Cited By:

0

0

0

Review Article

5. Lutetium-177-Labeled Prostate-Specific Membrane Antigen-617 for Molecular Imaging and Targeted Radioligand Therapy of Prostate Cancer

Rien Ritawidya , Hendris Wongso , Nurmaya Effendi , Anung Pujiyanto, Wening Lestari , Herlan Setiawan , Titis Sekar Humani*

Adv Pharm Bull. 2023;13(4): 701-711. doi: 10.34172/apb.2023.079

PMCID: PMC10676551 PMID: 38022814

Article

PDF

Full Text

XML

Cited By:

4